Michelle McMurry-Heath sold $105k of BVS
director at Bioventus Inc.. 12,000 shares at an average of $8.79, traded Mar 11, 2026, filed Mar 13, 2026.
Score components
- +15RoleDirector
- +10Trade size$105k at market
- +5Share of holdings soldSold 21% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +5.1%, 3m -1.3%, 6m +50.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001904156-26-000002, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 11, 2026 | SOpen-market sale Class A Common Stock | -12,000 | $8.79 | $105k | 44,997 | Mar 13, 2026 |
Related signals
Other insiders at Bioventus Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | BVSsell Bioventus Inc. | Guy P Nohra director | $76k 10,000 shares | -8% | |
| 31Weak | BVSsell Bioventus Inc. | Michelle McMurry-Heath director | $131k 17,701 shares | -24% | |
| 10Weak | Bioventus Inc. | Church Katrina J SVP & Chief Compliance Officer | $9,712 1,283 shares | -2% | |
| 10Weak | Bioventus Inc. | Anthony D'Adamio SVP & General Counsel | $22k 2,958 shares | -2% | |
| 22Weak | Bioventus Inc. | Mark Leonard Singleton SVP & CFO | $29k 3,875 shares | -3% | |
| 24Weak | Bioventus Inc. | Mark Leonard Singleton SVP & CFO | $54k 5,479 shares | -4% | |
| 15Weak | Bioventus Inc. | Anthony D'Adamio SVP & General Counsel | $25k 2,615 shares | -2% | |
| 10Weak | Bioventus Inc. | Church Katrina J SVP & Chief Compliance Officer | $9,926 1,018 shares | -2% | |
| 10Weak | Bioventus Inc. | Church Katrina J SVP & Chief Compliance Officer | $16k 1,537 shares | -3% | |
| 16Weak | Bioventus Inc. | Anthony D'Adamio SVP & General Counsel | $45k 4,380 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.